OccuRx
Melbourne
About OccuRx
OccuRx, a Melbourne-based biopharmaceutical company, was established in 2014 with venture funding from the Medical Research Commercialisation Fund, Brandon Capital Partners and Uniseed. The Company’s primary focus is on the development of innovative therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $21.2M
- Funding stage: M&A
- Last round: Series B (Sep 2022)
- Website: occurx.com
- Phone: +61396570704
Industries & Categories
Biopharma, Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/occurx-10315 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.